Wall Street Journal 9/4/2008, Warning for RA Drugs

[Guest guest]

Just in case we don't have enough side effects, the Wall Street Journal

posted an article today re: Fungel Infection:

The FDA said this morning that the drugs' labels need to call out the

risk of histoplasmosis, a potentially deadly fungal infection,

associated with four drugs: J & J's Remicade, Abbott's Humira, UCB SA's

Cimzia and Enbrel, co-marketed by Amgen and Wyeth. The drugs are used

to treat rheumatoid arthritis and Crohn's disease, among other

conditions.

If you want to read the whole article:

http://blogs.wsj.com/health/2008/09/04/one-more-warning-for-rheumatoid-

arthritis-drugs/